parallel randomized trial
SEMAT
The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and Obesity
Design
Conduct and analysis
Arms
| Arm | Treatment | Background | Randomized | Analyzed | Completed treatment |
|---|---|---|---|---|---|
| A1 | Semaglutide 1.0 mg subcutaneous once weekly Semaglutide 1 mg | metformin 1000 mg twice daily with or without sulfonylurea; lifestyle: standard | 13 | 13 | |
| A2 | Testosterone Testosterone undecanoate | metformin 1000 mg twice daily with sulfonylurea or DPP-4 inhibitor; lifestyle: standard | 12 | 12 |
Baseline characteristics
As printed in the trial reports or registry, per arm or for the whole trial.
| Characteristic | Statistic | Semaglutide 1.0 mg subcutaneous once weekly A1 | Testosterone A2 | Whole trial ALL |
|---|---|---|---|---|
| age | median (years) | 50 | ||
| age | q1 (years) | 46.1 | ||
| age | q3 (years) | 59.7 | ||
| bmi | median (kg/m2) | 35.9 | 35.8 | |
| bmi | q1 (kg/m2) | 32.8 | 32.7 | |
| bmi | q3 (kg/m2) | 38.7 | 39.9 | |
| diabetes duration | mean (years) | 4 | ||
| hba1c | median (percent) | 7.1 | 7.2 | |
| hba1c | q1 (percent) | 6.7 | 6.8 | |
| hba1c | q3 (percent) | 8 | 8.0 | |
| metformin use | percent | 100 | ||
| other hypertension | percent | 68 | ||
| other male | n | 25 | ||
| other sulfonylurea use | percent | 60 | ||
| weight | median (kg) | 115 | 111.5 | |
| weight | q1 (kg) | 102 | 101.7 | |
| weight | q3 (kg) | 120 | 125.2 |
Analyses this trial contributes to
- HbA1c changeType 2 diabetes (adults); weeks 20 to 36 (target week 26); network meta-analysis
- HbA1c changeType 2 diabetes (adults); weeks 20 to 36 (target week 26); network meta-analysis
- Body weight change in kilograms (diabetes)Type 2 diabetes (adults); weeks 20 to 36 (target week 26); network meta-analysis
- Body weight change in kilograms (diabetes)Type 2 diabetes (adults); weeks 20 to 36 (target week 26); network meta-analysis
Results
6 adjudicated result lines, grouped by outcome. Open an outcome to see its values.
HbA1c change (2 lines; O01)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 24 | A1 | change | percent | 13 | not stated; randomized; R0019948:Table 1 | ||
| 24 | A2 | change | percent | 12 | not stated; randomized; R0019948:Table 1 |
Body weight change in kilograms (diabetes) (2 lines; O02)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 24 | A1 | change | kg | 13 | not stated; randomized; R0019948:Table 1 | ||
| 24 | A2 | change | kg | 12 | not stated; randomized; R0019948:Table 1 |
Health related quality of life total score (any instrument) (2 lines; O24C)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 24 | A1 | change | points | 13 | not stated; randomized; R0019948:Table 3 | ||
| 24 | A2 | change | points | 12 | not stated; randomized; R0019948:Table 3 |